AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other CVRM medicines — Europe product sales by Year
Other CVRM medicines — Europe product sales ($M) ($M)
AstraZeneca Other CVRM medicines — Europe product sales: $158M in FY2025, up 8.2% from a year earlier.
Where the FY2025 figure comes from
“|| Other CVRM | 534 | (28) | (28) | 49 | (74) | 262 | 4 | 5 | 158 | (30) | (32) | 65 | (17) | (17)”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other CVRM medicines — Europe product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 158 | +8.2% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 146 | +33.9% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 109 | -14.8% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 128 | +141.5% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 53 | -69.9% | Form 6-K FY2021Q4 Earnings Release ↗ |
| FY2020 | Dec 31, 2020 | 176 | – | Form 6-K FY2020Q4 Earnings Release ↗ |
Breakdown
What makes up other CVRM medicines — Europe product sales
Cite this data
StockData. (2026). AstraZeneca Other CVRM medicines — Europe product sales ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-cvrm-eu
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.